GlycoMira
Pre-clinicalGlycoMira Therapeutics, Inc. is a preclinical-stage biopharmaceutical company developing a new class of innate immune system modulators based on polysaccharides that naturally occur within the body. GlycoMira’s dedicated team is working tirelessly toward a vision that will transform the way cancer is treated.
Founded
2007
Focus
Biologics
About
GlycoMira Therapeutics, Inc. is a preclinical-stage biopharmaceutical company developing a new class of innate immune system modulators based on polysaccharides that naturally occur within the body. GlycoMira’s dedicated team is working tirelessly toward a vision that will transform the way cancer is treated.
Funding History
2Total raised: $4.3M
Grant$2.5MNational Institutes of HealthSep 15, 2021
Seed$1.8MUniversity of Utah PartnersMay 15, 2019
Company Info
TypePrivate
Founded2007
LocationSalt Lake City, United States
StagePre-clinical
Contact
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile